Antisense to c-myc for treatment of polycystic kidney disease

Details Antisense to c-myc for treatment of polycystic kidney disease Antisense to c-myc for treatment of polycystic kidney disease

C - Chemistry, Metallurgy

12

N

C12N 15/11 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) A61P 13/12 (2006.01) C07H 21/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2374499

A method of treating polycystic kidney disease by administering an oligonucleotide antisense to <i>c-myc</i> is described. The antisense oligonucleotide is preferably a morpholino oligonucleotide.

L'invention concerne une méthode de traitement de la polykystose rénale par administration d'un oligonucléotide antisens de <i>c-myc</i>. L'oligonucléotide antisens est, de préférence, un morpholino oligonucléotide.

Affiliated with

Also associated with

Rating

Antisense to c-myc for treatment of polycystic kidney disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense to c-myc for treatment of polycystic kidney disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense to c-myc for treatment of polycystic kidney disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2076536